Exact Mass: 506.3216522
Exact Mass Matches: 506.3216522
Found 500 metabolites which its exact mass value is equals to given mass value 506.3216522
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
C24H42O11 (506.27269820000004)
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
Theasapogenol A
Theasapogenol A is found in tea. Sapogenol isolated from seeds of china tea and other plants. May or may not be present in the leaves. Theasapogenol A is found together with various acylated derivation and their glucosides for which refs. are give Sapogenol isolated from seeds of china tea and other plants. May or may not be present in the leaves. Found together with various acylated derivs. and their glucosides for which refs. are given. Theasapogenol A is found in tea.
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
C24H42O11 (506.27269820000004)
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea. (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of leaves of Camellia sinensis var. sinensis (China tea). Constituent of leaves of Camellia sinensis variety sinensis (China tea). (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea.
(5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide
(5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide is found in fruits. (5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide is a constituent of Physalis peruviana (Cape gooseberry). Constituent of Physalis peruviana (Cape gooseberry). (5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide is found in fruits.
Ixabepilone
C27H42N2O5S (506.28142820000005)
Ixabepilone is an epothilone B analog developed by Bristol-Myers Squibb as a cancer drug. On October 16, 2007, the U.S. Food and Drug Administration approved ixabepilone for the treatment of aggressive metastatic or locally advanced breast cancer no longer responding to currently available chemotherapies. Ixabepilone is administered through injection, and will be marketed under the trade name Ixempra. [Wikipedia] Ixabepilone is a semisynthetic analogue of epothilone B. It has a lactone lactam modification that
Chenodeoxycholylasparagine
Chenodeoxycholylasparagine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholylasparagine consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Asparagine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholylasparagine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholylasparagine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Deoxycholylasparagine
Deoxycholylasparagine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholylasparagine consists of the bile acid deoxycholic acid conjugated to the amino acid Asparagine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholylasparagine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholylasparagine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Bemcentinib
Anadur
Chromogenic Substrate S-2266
R1-Barrigenol
R1-barrigenol is a member of the class of compounds known as triterpenoids. Triterpenoids are terpene molecules containing six isoprene units. R1-barrigenol is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). R1-barrigenol can be found in tea, which makes r1-barrigenol a potential biomarker for the consumption of this food product.
Gymnemagenin
Gymnemagenin is a natural product found in Gymnema sylvestre with data available. See also: Gymnema sylvestre leaf (part of). Gymnemagenin is a triterpenoid isolated from G. sylvestre. Gymnemagenin is an agent for diabetes and obesity and also possesses antiviral properties[1][2]. Gymnemagenin is a triterpenoid isolated from G. sylvestre. Gymnemagenin is an agent for diabetes and obesity and also possesses antiviral properties[1][2].
2-(e-Methylbutanoyl),3,17-di-Ac-2,3,16,17-Phyllocladanetetrol
11-O-acetyl-12-O-isovaleroyl-17beta-marsdenin|8-hydroxydrevogenin A
(20R,22R)-6-oxo-2beta,3beta,14alpha,25-tetrahydroxy-5beta-cholest-7-en-22-yl acetate|ecdysone 22-acetate
(24R)-6alpha,11alpha,16beta,24,25-pentahydroxycycloartan-3-one
Tanginol|Tanginol (3beta,6beta,7beta,16beta,23,28-Hexahydroxy-Delta12-oleanen)
amphimedoside A|N-methoxy-N-(16-pyridin-3-ylhexadec-11-yn-1-yl)-beta-D-glucopyranosylamine
3-(1,2-ethanediol)-24-methylcholesta-8(9),22E-diene-3beta,5alpha,6alpha,7alpha,11alpha-pentaol
(1R,2E,4S,5R,6S,7E,10S,11S,12R)-5,6,10,18-tetraacetoxy-2,7-dolabelladiene|5,6,10,18-Tetraacetoxy-2,7-dolabelladiene
6alpha-O-(6-O-acetyl-beta-D-glucopyranosyl)-15,16-epoxycleroda-3,13(16),14-triene|salvigreside D
(2alpha,3alpha,12alpha,17R)-12-methoxy-19(18->17)-abeo-28-norolean-13(18)-ene-2,3,23,24,29-pentol
(20S,22R,24S,25R)-5alpha,6beta,14alpha,17beta,20-pentahydroxy-1-oxowitha-2-en-22,26-olide|24,25-dihydrowithanolide S
9,19-Cycloergostan-3-one, 22,24,25,28-tetrahydroxy-4-(hydroxymethyl)-14-methyl-, (5.alpha.)-
(2S)-2,3,9,10-tetrahydro-2-[3,4-dihydro-8-(3-ethoxy-3-methylbutyl)-2,2-dimethyl-2H-chromen-6-yl]-8,8-dimethyl-4H,8H-pyrano[2,3-f]chromen-4-one|tonkinochromane E
(2E)-3-[3,4-dihydro-8-(3-ethoxy-3-methylbutyl)-2,2-dimethyl-2H-chromen-6-yl]-1-(3,4-dihydro-5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one|tonkinochromane F
(2S,1R,2R,4S)-fenchyl-3,4-dihydro-5-hydroxy-2,7-dimethyl-8-(3-methyl-2-butenyl)-2-(4-methyl-1,3-pentadienyl)-2H-1-benzopyran-6-carboxylate
3beta,4beta,5alpha,6beta,27-pentahydroxy-1-oxo-with-24-enolide
digitoxigenin-3-O-beta-d-xyloside|digitoxigenyl beta-D-xyloside
(2R,1S,2R,4S)-bornyl-3,4-dihydro-5-hydroxy-2,7-dimethyl-8-(3-methyl-2-butenyl)-2-(4-methyl-1,3-pentadienyl)-2H-1-benzopyran-6-carboxylate
2alpha,3beta,12beta,13beta-tetrahydroxy-urs-28-oic acid|psiguanin C
(3R)-malonyl-(13S)-hydroxy-cheilanth-17-en-19-oate
14-O-alpha-L-rhamnopyranosyl-(2E,4E,7R,8E,10E,12E,14R)-7,9,13,17-tetramethyl-7,14-dihydroxy-2,4,8,10,12,16-octadecahexaenoic acid
2alpha,7alpha-diacetoxy-6beta-isovaleroxylabda-8,13-dien-15-ol
3,4-seco-olean-12-en-4,15alpha,22alpha,24-tetraol-3-oic acid
(+)-20S-3-(benzoylamino)-20-(dimethylamino)-5alpha-pregn-2-en-4beta-yl acetate
(20R,22R)-20,22-(R-ethane-1,1-diyldioxy)-2beta,3beta,11alpha,14alpha-tetrahydroxy-5beta-cholest-7-en-6-one|20,22-O-(R-ethylidene)-ajugasterone C
(2beta,3beta,16alpha,20R)-2,3,16,20,25-Pentahydroxy-5-cucurbiten-22-one|2,3,16,20,25-pentahydroxy-9-methyl-19-norlanost-5-en-22-one
(2alpha,3beta,12beta,13beta)-2,3,12,13-tetrahydroxyoleanan-28-oic acid|serrulatin E
Asn Val Phe Lys
Phe Val Ile Glu
Protoescigenin
Protoescigenin is a natural product found in Aesculus indica with data available. Protoescigenin is the main aglycone of horse chestnut saponin mixture known as escin. Protoescigenin is selected as substrate for exploratory chemistry towards selective protection, followed by propargyl ether formation and subsequent condensation with azido-monosaccharides, to obtain novel triazole linked conjugates of the triterpene[1].
19-hydroxy-18-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosanoic acid
C30H50O6_13,17,24,25-Tetrahydroxy-16,23-epoxydammaran-3-one
C30H38N2O5_(1E)-6-Hydroxy-12-(1H-indol-3-ylmethyl)-7-methoxy-4,13,13a-trimethyl-5,6,7,8,12,12a,13,13a,14a,14b-decahydro-3H-cycloundeca[d]oxireno[f]isoindole-9,10(4H,11H)-dione
((4R)-4-((3R,5R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine
Asp Phe Ile Ile
Asp Phe Ile Leu
Asp Phe Leu Ile
Asp Phe Leu Leu
Asp Ile Phe Ile
Asp Ile Phe Leu
Asp Ile Ile Phe
Asp Ile Leu Phe
Asp Leu Phe Ile
Asp Leu Phe Leu
Asp Leu Ile Phe
Asp Leu Leu Phe
Glu Phe Ile Val
Glu Phe Leu Val
Glu Phe Val Ile
Glu Phe Val Leu
Glu Ile Phe Val
Glu Ile Val Phe
Glu Leu Phe Val
Glu Leu Val Phe
Glu Val Phe Ile
Glu Val Phe Leu
Glu Val Ile Phe
Glu Val Leu Phe
Phe Asp Ile Ile
Phe Asp Ile Leu
Phe Asp Leu Ile
Phe Asp Leu Leu
Phe Glu Ile Val
Phe Glu Leu Val
Phe Glu Val Ile
Phe Glu Val Leu
Phe Gly Lys Arg
Phe Gly Arg Lys
Phe Ile Asp Ile
Phe Ile Asp Leu
Phe Ile Glu Val
Phe Ile Ile Asp
Phe Ile Leu Asp
Phe Ile Val Glu
Phe Lys Gly Arg
Phe Lys Asn Val
Phe Lys Arg Gly
Phe Lys Val Asn
Phe Leu Asp Ile
Phe Leu Asp Leu
Phe Leu Glu Val
Phe Leu Ile Asp
Phe Leu Leu Asp
Phe Leu Val Glu
Phe Asn Lys Val
Phe Asn Val Lys
Phe Arg Gly Lys
Phe Arg Lys Gly
Phe Val Glu Ile
Phe Val Glu Leu
Phe Val Lys Asn
Phe Val Leu Glu
Phe Val Asn Lys
Gly Phe Lys Arg
Gly Phe Arg Lys
Gly Lys Phe Arg
Gly Lys Arg Phe
Gly Arg Phe Lys
Gly Arg Lys Phe
Ile Asp Phe Ile
Ile Asp Phe Leu
Ile Asp Ile Phe
Ile Asp Leu Phe
Ile Glu Phe Val
Ile Glu Val Phe
Ile Phe Asp Ile
Ile Phe Asp Leu
Ile Phe Glu Val
Ile Phe Ile Asp
Ile Phe Leu Asp
Ile Phe Val Glu
Ile Ile Asp Phe
Ile Ile Phe Asp
Ile Ile Val Tyr
Ile Ile Tyr Val
Ile Leu Asp Phe
Ile Leu Phe Asp
Ile Leu Val Tyr
Ile Leu Tyr Val
Ile Val Glu Phe
Ile Val Phe Glu
Ile Val Ile Tyr
Ile Val Leu Tyr
Ile Val Tyr Ile
Ile Val Tyr Leu
Ile Tyr Ile Val
Ile Tyr Leu Val
Ile Tyr Val Ile
Ile Tyr Val Leu
Lys Phe Gly Arg
Lys Phe Asn Val
Lys Phe Arg Gly
Lys Phe Val Asn
Lys Gly Phe Arg
Lys Gly Arg Phe
Lys Lys Met Thr
C21H42N6O6S (506.28863920000003)
Lys Lys Thr Met
C21H42N6O6S (506.28863920000003)
Lys Met Lys Thr
C21H42N6O6S (506.28863920000003)
Lys Met Thr Lys
C21H42N6O6S (506.28863920000003)
Lys Asn Phe Val
Lys Asn Val Phe
Lys Arg Phe Gly
Lys Arg Gly Phe
Lys Thr Lys Met
C21H42N6O6S (506.28863920000003)
Lys Thr Met Lys
C21H42N6O6S (506.28863920000003)
Lys Val Phe Asn
Lys Val Asn Phe
Leu Asp Phe Ile
Leu Asp Phe Leu
Leu Asp Ile Phe
Leu Asp Leu Phe
Leu Glu Phe Val
Leu Glu Val Phe
Leu Phe Asp Ile
Leu Phe Asp Leu
Leu Phe Glu Val
Leu Phe Ile Asp
Leu Phe Leu Asp
Leu Phe Val Glu
Leu Ile Asp Phe
Leu Ile Phe Asp
Leu Ile Val Tyr
Leu Ile Tyr Val
Leu Leu Asp Phe
Leu Leu Phe Asp
Leu Leu Val Tyr
Leu Leu Tyr Val
Leu Val Glu Phe
Leu Val Phe Glu
Leu Val Ile Tyr
Leu Val Leu Tyr
Leu Val Tyr Ile
Leu Val Tyr Leu
Leu Tyr Ile Val
Leu Tyr Leu Val
Leu Tyr Val Ile
Leu Tyr Val Leu
Met Lys Lys Thr
C21H42N6O6S (506.28863920000003)
Met Lys Thr Lys
C21H42N6O6S (506.28863920000003)
Met Thr Lys Lys
C21H42N6O6S (506.28863920000003)
Asn Phe Lys Val
Asn Phe Val Lys
Asn Lys Phe Val
Asn Lys Val Phe
Asn Val Lys Phe
Arg Phe Gly Lys
Arg Phe Lys Gly
Arg Gly Phe Lys
Arg Gly Lys Phe
Arg Lys Phe Gly
Arg Lys Gly Phe
Thr Lys Lys Met
C21H42N6O6S (506.28863920000003)
Thr Lys Met Lys
C21H42N6O6S (506.28863920000003)
Thr Met Lys Lys
C21H42N6O6S (506.28863920000003)
Val Glu Phe Ile
Val Glu Phe Leu
Val Glu Ile Phe
Val Glu Leu Phe
Val Phe Glu Ile
Val Phe Glu Leu
Val Phe Ile Glu
Val Phe Lys Asn
Val Phe Leu Glu
Val Phe Asn Lys
Val Ile Glu Phe
Val Ile Phe Glu
Val Ile Ile Tyr
Val Ile Leu Tyr
Val Ile Tyr Ile
Val Ile Tyr Leu
Val Lys Phe Asn
Val Lys Asn Phe
Val Leu Glu Phe
Val Leu Phe Glu
Val Leu Ile Tyr
Val Leu Leu Tyr
Val Leu Tyr Ile
Val Leu Tyr Leu
Val Asn Phe Lys
Val Asn Lys Phe
Val Tyr Ile Ile
Val Tyr Ile Leu
Val Tyr Leu Ile
Val Tyr Leu Leu
Tyr Ile Ile Val
Tyr Ile Leu Val
Tyr Ile Val Ile
Tyr Ile Val Leu
Tyr Leu Ile Val
Tyr Leu Leu Val
Tyr Leu Val Ile
Tyr Leu Val Leu
Tyr Val Ile Ile
Tyr Val Ile Leu
Tyr Val Leu Ile
Tyr Val Leu Leu
Ixabepilone
C27H42N2O5S (506.28142820000005)
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
(5alpha,6beta,14alpha,20R,22R)-5,6,14,20,27-Pentahydroxy-1-oxowith-24-enolide
Theasapogenol A
14-O-(alpha-L-rhamnopyranosyl)-7S,14R-dihydroxy-7,9,13,17-tetramethyl-2E,4E,8E,10E,12E,16E-octadecahexaenoic acid
(E)-12-((1H-indol-3-yl)methyl)-6-hydroxy-7-methoxy-4,13,13a-trimethyl-3,5,6,7,8,11,12,12a,13,13a,14a,14b-dodecahydro-9H-cycloundeca[d]oxireno[2,3-f]isoindole-9,10(4H)-dione
Combretanone B
A pentacyclic triterpenoid that is 9beta,19-cyclolanostane substituted by an oxo group at position 3 and hydroxy groups at positions 7, 23R*, 24S*, 25 and 28. It has been isolated from the leaves of Combretum quadrangulare.
[2-(hexanoyloxymethyl)-2-[[3-hydroxy-2,2-bis(hydroxymethyl)propoxy]methyl]-3-propoxypropyl] heptanoate
Cholan-24-oic acid,6-ethylidene-3-hydroxy-7-oxo-,phenylmethyl ester, (3α,5β)-
2,3-Bis[(1-oxooctyl)oxy]propyl beta-D-galactopyranoside
Bemcentinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials, Guide to PHARMACOLOGY C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
[(E)-2-acetamido-3-hydroxyoctadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(2S,3R,4S,6R)-2-[[(3E,5S,6S,7S,9R,11E,13E,15S,16R)-16-ethyl-5,7,9,15-tetramethyl-2,10-dioxo-1-oxacyclohexadeca-3,11,13-trien-6-yl]oxy]-3-hydroxy-6-methyloxan-4-yl]-dimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(1Z,9Z)-octadeca-1,9-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
C26H53NO6P+ (506.36103080000004)
[3-carboxy-2-[(4E,7E,10E,13E,16E)-19,20-dihydroxydocosa-4,7,10,13,16-pentaenoyl]oxypropyl]-trimethylazanium
2-[[3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C25H49NO7P+ (506.32464740000006)
1,2-Dioctanoyl-3-beta-d-galactosyl-sn-glycerol
A 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol in which the acyl groups at positions 1 and 2 are specified as octanoyl.
Ile-Leu-Val-Tyr
A tetrapeptide composed of L-isoleucine, L-leucine, L-valine and L-tyrosine joined in sequence by peptide linkages.
8-[1-[4-(Dimethylamino)phenyl]-3-(1-pyrrolidinyl)propyl]-5,7-dimethoxy-4-pentyl-1-benzopyran-2-one
C31H42N2O4 (506.31444120000003)
1alpha,25-Dihydroxy-2beta-(1,3-dihydroxypropoxy)-cholecalciferol
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
1-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-3-propan-2-ylurea
(1R)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
(1S)-1-(hydroxymethyl)-7-methoxy-2-[(3-methoxyphenyl)methyl]-N-propyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]carboxamide
3-[(S)-2-Azido-8-[(3,6-diethoxy-5beta-isopropyl-2,5-dihydropyrazin)-2alpha-yl]octanoyl]-4beta-isopropyloxazolidin-2-one
2-[[(2R)-3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C25H49NO7P+ (506.32464740000006)
[(2E,6E,10E,14E,18E)-3,7,11,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaenyl] dihydrogen phosphate
C30H51O4P (506.35247760000004)
[2-Octanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropyl] octanoate
[(E)-3-hydroxy-2-(octanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(propanoylamino)heptadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(pentanoylamino)pentadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(nonanoylamino)undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(butanoylamino)-3-hydroxyhexadec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(heptanoylamino)-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-3-hydroxy-2-(undecanoylamino)non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(hexanoylamino)-3-hydroxytetradec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[(E)-2-(decanoylamino)-3-hydroxydec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-Heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] nonanoate
[1-Acetyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tetradecanoate
[1-Hexanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] decanoate
[1-Butanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] dodecanoate
[1-Propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] tridecanoate
[1-Pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] undecanoate
[(E)-2-(dodecanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (Z)-heptadec-9-enoate
(1-phosphonooxy-3-propanoyloxypropan-2-yl) (Z)-nonadec-9-enoate
(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (Z)-pentadec-9-enoate
(1-butanoyloxy-3-phosphonooxypropan-2-yl) (Z)-octadec-9-enoate
(1-hexanoyloxy-3-phosphonooxypropan-2-yl) (Z)-hexadec-9-enoate
(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tridec-9-enoate
(1-acetyloxy-3-phosphonooxypropan-2-yl) (Z)-icos-11-enoate
(1-octanoyloxy-3-phosphonooxypropan-2-yl) (Z)-tetradec-9-enoate
19-Hydroxy-18-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyicosanoic acid
((4R)-4-((3R,5R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine
2-[hydroxy-[2-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
C26H53NO6P+ (506.36103080000004)
2-[[(2R)-3-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C25H49NO7P+ (506.32464740000006)
[1-carboxy-3-[2-hydroxy-3-[(4E,7E,10E,13E,16E)-nonadeca-4,7,10,13,16-pentaenoyl]oxypropoxy]propyl]-trimethylazanium
2-[[3-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C25H49NO7P+ (506.32464740000006)
(1S,3S,7S,10R,11S,12S,16R)-7,11-dihydroxy-8,8,10,12,16-pentamethyl-3-[1-(2-methyl-4-thiazolyl)prop-1-en-2-yl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione
C27H42N2O5S (506.28142820000005)